Researchers uncover how drug-resistant fungi survive hospital treatments

What Happened

Fungal infections in humans are rising sharply, with dangerous strains like Candida auris causing severe bloodstream infections in intensive care units and a mortality rate of thirty to forty percent. A recent study published in Nature Communications by researchers Kaustuv Sanyal and Aswathy Narayanan has examined clinical isolates of this pathogen across India to understand its high resistance to common medicines. More than ninety percent of these isolates are resistant to azole-based drugs like fluconazole, while thirty percent resist polyenes.

Resistance Mechanisms

When exposed to fluconazole, C. auris fights back by making extra copies of the Erg11 gene, which leads to higher production of a target fat called ergosterol and cancels out the drug. Against echinocandin drugs like caspofungin, the pathogen uses mutations in the Fks1 gene to survive doses up to sixteen micrograms per milliliter. Researchers also found a strange survival pattern called the Eagle effect, where exceptionally high doses of caspofungin trigger the fungus to produce large amounts of chitin, repairing cell wall damage and keeping the organism alive.

Expert Insights

Experts suggest that global warming is driving this shift through the mammalian selection hypothesis, as rising temperatures select for heat-tolerant fungi that can survive inside human bodies. Shivaprakash Rudramurthy of PGIMER notes that roughly twenty percent of hospital infections are now fungal, though most Indian hospitals lack the infrastructure to identify them. While Prof. Sanyal recommends combination therapies to block the cellular repair pathways, Dr. Sriram Varahan suggests moving away from chemical battles entirely toward gentler alternatives that stop fungi from causing disease without killing them outright.

Context

Fungi naturally adapt to harsh chemical environments over time through genetic changes and duplication. Understanding these exact biological survival methods helps medical researchers design better diagnostic tests and more effective treatment plans for patients.